Intended for healthcare professionals


Audit of implantable cardioverter-defibrillators in a single UK centre

BMJ 1999; 318 doi: (Published 22 May 1999) Cite this as: BMJ 1999;318:1416
  1. Sandeep Gupta, Specialist registrar,
  2. Hasan Hasan, Senior house officer,
  3. Oswaldo Valencia, Research fellow,
  4. Sue Jones, Senior pacing coordinator,
  5. Edward Rowland, Consultant cardiologist,
  6. A John Camm, Professor of cardiology,
  7. Charles W Pumphrey, Consultant cardiologist,
  8. David E Ward, Consultant cardiologist
  1. Department of Cardiology, St George's Hospital, London SW17 OQT

    EDITOR—We support Causer and Connolly's editorial emphasising the value of implantable cardioverter-defibrillators in patients with life threatening ventricular arrhythmias.1 A recent audit conducted in our cardiac unit highlights two additional issues: psychosocial concerns of patients and cost implications. We reviewed clinical records and psychosocial structured questionnaires of the 42 patients receiving their first implantable cardioverter-defibrillator (through pectoral routes) between January 1995 and February 1998 (table). To our knowledge, this is the first reported series of such patients in the …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription